7/20/2021NMPA Revises Packages Insert of Propranolol Tablets

7/20/2021South Korea's Medipost Drops Joint Venture Plan in China

7/20/2021Eluminex Bio Licenses FibroGen's Biosynthetic Cornea Technology and Re...

7/19/2021CDE Issues the Writing Guidelines and Generic Format of the Production...

7/19/2021Ascentage Enters R&D Deal with the National Cancer Institute for Clin...

7/19/2021Frontier Reports Positive Clinical Results for First Long-acting Injec...

7/19/2021Junshi Bio and Immorna Announce JV for mRNA-based Therapeutics and Va...

7/19/2021Pharma DJ: ADCs and I/O Therapies Attract Massive Investments

7/16/2021CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...

7/16/2021NHSA Issues the BMI Management Procedures for Disease Group-based Diag...

7/16/2021Recent Executive Moves

7/16/2021Chinese Premier Calls for More Efforts to Enhance BMI Access, Budget M...

7/15/2021China Increases Subsidies for Basic Public Health Services

7/15/2021China Sees Substantial Declines in Infectious Diseases

7/15/2021Kintor Pharma Ties Up with Fosun for Covid-19 Treatment Proxalutamide ...

7/15/2021China Reportedly Eyeing BioNTech COVID-19 Vaccine as Booster for Its P...

7/15/2021HUTCHMED's MAA for Surufatinib Validated by the European Medicines Age...

7/15/2021CANbridge's CAN106 IND Approved in China for Paroxysmal Nocturnal Hemo...

7/15/2021A Chinese I/O Biotech Looking To Turn Around An Old Novartis Program G...

7/14/2021PharmaDJ's China Licensing Deals Tracker: May 2021

7/14/2021NMPA Announces OTC Switch of Four Rx Drug Products

7/14/2021Innovent and Ascentage Reach Strategic Deal for Olverembatinib in Chin...

7/14/2021Teva's NDA for Copaxone Injection Accepted by the Chinese CDE

7/14/2021AstraZeneca Granted Chinese Approval for New SCLC Indication of Imfinz...

7/13/2021New Report: Global and Chinese CDMO Markets to Rise 11.2% and 19.9% CA...

7/13/2021Biogen Licenses Certain Rights of Anticancer Orelabrutinib from InnoCa...

7/13/2021Kintor Pharma Greenlighted for Pyrilutamide's Phase II Trial in the US

7/13/2021Everest Medicines and Tencent Enters Strategic Commercial Partnership

7/13/2021Takeda's NSCLC Drug Mobocertinib NDA Accepted with Priority Review in ...

7/13/2021CDE Seeks Comments on Draft ICH Guidelines S12

Page:199/795 Total number of articles:23843: [First][<<] [197] [198] [199] [200] [201] [>>] [End]